Clinical Outcomes of Intravenous Iron Therapy in Systolic Heart Failure Patients Receiving SGLT2 Inhibitors. Alruwaili W, Ahmed S, Berzingi S, Atti L, et al. Am J Cardiol 2025 Jun 6:S0002-9149(25)00362.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Alruwaili W, Ahmed S, Berzingi S, Atti L, et al. Clinical Outcomes of Intravenous Iron Therapy in Systolic Heart Failure Patients Receiving SGLT2 Inhibitors. Am J Cardiol 2025 Jun 6:S0002-9149(25)00362.
PMID: 40484263